ArticleViruses2020

Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity.

Kiira Kalke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.